{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:15:32Z","timestamp":1770815732985,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["12GRNT12040211"],"award-info":[{"award-number":["12GRNT12040211"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR002533"],"award-info":[{"award-number":["TL1 TR002533"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.healun.2021.05.020","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T07:04:06Z","timestamp":1623481446000},"page":"917-925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients"],"prefix":"10.1016","volume":"40","author":[{"given":"Kris","family":"Oreschak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Rafaels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrut V.","family":"Ambardekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly M.","family":"Deininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RobertL.","family":"PageII","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina L.","family":"Aquilante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.05.020_bib0001","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.020_bib0003","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1399-0012.2008.00893.x","article-title":"Management of leukopenia in kidney and pancreas transplant recipients","volume":"22","author":"Hartmann","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0004","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.healun.2007.10.012","article-title":"Mycophenolate mofetil dose reduction for gastrointestinal intolerance is associated with increased rates of rejection in heart transplant patients","volume":"27","author":"Galiwango","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0005","doi-asserted-by":"crossref","first-page":"e12896","DOI":"10.1111\/tid.12896","article-title":"Cytomegalovirus infection in heart transplantation: a single center experience","volume":"20","author":"Echenique","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.05.020_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015828802490","article-title":"Bioavailability improvement of mycophenolic acid through amino ester derivatization","volume":"7","author":"Lee","year":"1990","journal-title":"Pharm Res"},{"key":"10.1016\/j.healun.2021.05.020_bib0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/dmd.104.001651","article-title":"Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism","volume":"33","author":"Picard","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.healun.2021.05.020_bib0008","first-page":"925","article-title":"Pharmacokinetics of mycophenolate mofetil (RS61443): a short review","volume":"28","author":"Bullingham","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2021.05.020_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.healun.2021.05.020_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12659\/AOT.883812","article-title":"Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation","volume":"18","author":"Roan","year":"2013","journal-title":"Ann Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0011","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/petr.12542","article-title":"The effect of MMF dose and trough levels on adverse effects in pediatric heart transplant recipients","volume":"19","author":"Siddiqi","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0012","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/00912709922008452","article-title":"Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects","volume":"39","author":"Jung","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.healun.2021.05.020_bib0013","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.healun.2021.05.020_bib0014","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/dmd.111.042036","article-title":"Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs","volume":"40","author":"Cheng","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.healun.2021.05.020_bib0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis","volume":"13","author":"Battiwalla","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0016","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/AAC.02130-15","article-title":"Contribution of population pharmacokinetics to dose optimization of ganciclovir-valganciclovir in solid-organ transplant patients","volume":"60","author":"Padulles","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.healun.2021.05.020_bib0017","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.TP.0000164512.99703.AD","article-title":"Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients","volume":"79","author":"Wiltshire","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.020_bib0018","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(19)31276-0","article-title":"Pharmacogenomics","volume":"394","author":"Roden","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2021.05.020_bib0019","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1592\/phco.30.11.1097","article-title":"Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study","volume":"30","author":"Ting","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.healun.2021.05.020_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.healun.2009.11.602","article-title":"Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients","volume":"29","author":"Ohmann","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0021","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.phrs.2016.07.012","article-title":"Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients","volume":"111","author":"Billat","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.healun.2021.05.020_bib0022","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/TP.0b013e3182488bb4","article-title":"Mycophenolic acid-related anemia and leucopenia in renal transplant recipients are related to genetic polymorphisms in CYP2C8","volume":"93","author":"Bouamar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.020_bib0023","doi-asserted-by":"crossref","first-page":"e13033","DOI":"10.1111\/petr.13033","article-title":"Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: influence of genes and drugs","volume":"21","author":"Varnell","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0024","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/FPC.0000000000000045","article-title":"Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients","volume":"24","author":"Woillard","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.healun.2021.05.020_bib0025","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0026","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0027","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/TP.0b013e318200e971","article-title":"Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation","volume":"91","author":"Jacobson","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.020_bib0028","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/TP.0000000000002625","article-title":"Genetic variants associated with immunosuppressant pharmacokinetics and adverse effects in the DeKAF genomics genome-wide association studies","volume":"103","author":"Oetting","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.020_bib0029","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1124\/mol.65.4.953","article-title":"Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1alpha and the caudal-related homeodomain protein 2","volume":"65","author":"Gregory","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.healun.2021.05.020_bib0030","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-895X(24)26503-2","article-title":"Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter","volume":"57","author":"Ishii","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.healun.2021.05.020_bib0031","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bcp.2006.03.016","article-title":"Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha","volume":"72","author":"Maher","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.healun.2021.05.020_bib0032","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1007\/s00125-006-0450-x","article-title":"Common variants in HNF-1 alpha and risk of type 2 diabetes","volume":"49","author":"Holmkvist","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.healun.2021.05.020_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3582616","article-title":"Identification of HNF4A mutation p.T130I and HNF1A mutations p.I27L and p.S487N in a Han Chinese family with early-onset maternally inherited type 2 diabetes","volume":"2016","author":"Yang","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.healun.2021.05.020_bib0034","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0092-8674(90)90687-A","article-title":"A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1","volume":"61","author":"Nicosia","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.healun.2021.05.020_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.trim.2013.05.005","article-title":"Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1alpha and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid","volume":"29","author":"Vu","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2021.05.020_bib0036","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1097\/TP.0000000000000913","article-title":"Design and implementation of the International Genetics and Translational Research in Transplantation Network","volume":"99","author":"International","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.020_bib0037","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10654-012-9754-y","article-title":"Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort","volume":"28","author":"Koller","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.healun.2021.05.020_bib0038","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fphar.2017.00712","article-title":"Improved progression-free survival in irinotecan-treated metastatic colorectal cancer patients carrying the HNF1A coding variant p.I27L","volume":"8","author":"Labriet","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.healun.2021.05.020_bib0039","first-page":"2182","article-title":"Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)","volume":"7","author":"Mathijssen","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.healun.2021.05.020_bib0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)38014-0","article-title":"Active efflux of CPT-11 and its metabolites in human KB-derived cell lines","volume":"288","author":"Chu","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.healun.2021.05.020_bib0041","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1126\/science.1089769","article-title":"Control of pancreas and liver gene expression by HNF transcription factors","volume":"303","author":"Odom","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.healun.2021.05.020_bib0042","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation - challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.05.020_bib0043","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1253\/circj.71.968","article-title":"Correlation between body mass index and leucopenia after administration of valganciclovir for cytomegalovirus infection in chinese cardiac recipients","volume":"71","author":"Chen","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.healun.2021.05.020_bib0044","first-page":"A2834","article-title":"Characteristics of patients who develop leukopenia after lung transplant","volume":"201","author":"Wu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2021.05.020_bib0045","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1073\/pnas.90.17.8073","article-title":"Expression cloning of rat renal Na+\/SO4(2-) cotransport","volume":"90","author":"Markovich","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2021.05.020_bib0046","doi-asserted-by":"crossref","first-page":"30235","DOI":"10.1074\/jbc.M806194200","article-title":"Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils","volume":"283","author":"Gijon","year":"2008","journal-title":"J Biol Chem"},{"issue":"Suppl s1","key":"10.1016\/j.healun.2021.05.020_bib0047","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/ajt.15676","article-title":"OPTN\/SRTR 2018 Annual Data Report: Heart","volume":"20","author":"Colvin","year":"2020","journal-title":"Am J Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821023421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821023421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:13:23Z","timestamp":1762355603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821023421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1053249821023421"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.05.020","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}